Compare QFIN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QFIN | PBH |
|---|---|---|
| Founded | 2016 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2018 | 2005 |
| Metric | QFIN | PBH |
|---|---|---|
| Price | $16.72 | $65.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $36.85 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 1.6M | 363.2K |
| Earning Date | 11-18-2025 | 02-05-2026 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | ★ 40.93 | N/A |
| EPS | ★ 6.93 | 4.04 |
| Revenue | ★ $2,752,357,572.00 | $1,110,479,000.00 |
| Revenue This Year | $16.96 | N/A |
| Revenue Next Year | N/A | $2.50 |
| P/E Ratio | ★ $2.42 | $16.11 |
| Revenue Growth | ★ 14.06 | N/A |
| 52 Week Low | $16.63 | $57.25 |
| 52 Week High | $48.94 | $90.04 |
| Indicator | QFIN | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 26.37 | 58.40 |
| Support Level | $17.20 | $64.34 |
| Resistance Level | $20.27 | $66.09 |
| Average True Range (ATR) | 0.71 | 1.61 |
| MACD | -0.15 | 0.14 |
| Stochastic Oscillator | 6.97 | 70.21 |
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.